Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Psychol Med ; 39(4): 645-54, 2009 Apr.
Article in English | MEDLINE | ID: mdl-18694537

ABSTRACT

BACKGROUND: Interpersonal communication problems are common among persons with schizophrenia and may be linked, in part, to deficits in theory of mind (ToM), the ability to accurately perceive the attitudes, beliefs and intentions of others. Particular difficulties might be expected in the processing of counterfactual information such as sarcasm or lies. METHOD: The present study included 50 schizophrenia or schizo-affective out-patients and 44 demographically comparable healthy adults who were administered Part III of The Awareness of Social Inference Test (TASIT; a measure assessing comprehension of sarcasm versus lies) as well as measures of positive and negative symptoms and community functioning. RESULTS: TASIT data were analyzed using a 2 (group: patients versus healthy adults) x 2 (condition: sarcasm versus lie) repeated-measures ANOVA. The results show significant effects for group, condition, and the group x condition interaction. Compared to controls, patients performed significantly worse on sarcasm but not lie scenes. Within-group contrasts showed that patients performed significantly worse on sarcasm versus lie scenes; controls performed comparably on both. In patients, performance on TASIT showed a significant correlation with positive, but not negative, symptoms. The group and interaction effects remained significant when rerun with a subset of patients with low-level positive symptoms. The findings for a relationship between TASIT performance and community functioning were essentially negative. CONCLUSIONS: The findings replicate a prior demonstration of difficulty in the comprehension of sarcasm using a different test, but are not consistent with previous studies showing global ToM deficits in schizophrenia.


Subject(s)
Communication , Comprehension , Deception , Interpersonal Relations , Personal Construct Theory , Psychotic Disorders/psychology , Schizophrenia/diagnosis , Schizophrenic Psychology , Adult , Chronic Disease , Female , Humans , Male , Psychotic Disorders/diagnosis , Social Adjustment , Videotape Recording
2.
Psychiatry Res ; 81(1): 57-65, 1998 Oct 19.
Article in English | MEDLINE | ID: mdl-9829651

ABSTRACT

In schizophrenia, relatively little is known about the association between deficits in emotion perception and basic neurocognitive functioning. The present study examined perception of emotion and a discrete set of neurocognitive functions in 28 treatment-resistant schizophrenic patients. Measures of emotion perception included a facial emotion identification test (still photographs presented on videotape), a voice emotion identification test (audiotape), and an affect perception test (brief interpersonal vignettes presented on videotape). Measures of neurocognitive functioning were selected based on hypothesized relationships to perception of emotion. These measures included: (a) Span of Apprehension task, a measure of early visual processing, visual scanning, and iconic read-out; (b) Degraded-Stimulus Continuous Performance Test, a measure of visual vigilance; and (c) Digit Span Distractibility Test, a measure of immediate or working memory. Among these measures, performance on the Span of Apprehension strongly correlated with performance on all three emotion perception tasks. The associations between perception of emotion and the other two measures were in the same direction, but were significantly smaller than those of the Span of Apprehension. These findings implicate the importance of early perceptual processing (i.e. visual scanning) in the ability of schizophrenic individuals to perceive emotion.


Subject(s)
Affect , Brain/physiology , Schizophrenia/diagnosis , Visual Perception/physiology , Adult , Cognition Disorders/diagnosis , Cognition Disorders/etiology , Cognition Disorders/psychology , Facial Expression , Female , Hospitalization , Humans , Male , Middle Aged , Neuropsychological Tests , Schizophrenia/complications , Schizophrenia/rehabilitation , Schizophrenic Psychology , Social Perception , Voice
3.
Schizophr Res ; 31(2-3): 159-65, 1998 May 25.
Article in English | MEDLINE | ID: mdl-9689720

ABSTRACT

Currently, little is known about the pharmacological effects of the new generation of antipsychotic medications on perception of emotion in schizophrenia. The present study was designed to compare the effects of risperidone versus haloperidol on the ability to perceive emotion in 20 treatment-resistant schizophrenia patients, using a double-blind design. Measures of emotion perception included a facial emotion identification test (still photographs presented on videotape), a voice emotion identification test (audiotape), and an affect perception test (brief interpersonal vignettes presented on videotape). These measures were administered during the final week of baseline and after 8 weeks of double-blind medication. Risperidone treatment produced a greater effect on patients' ability to perceive emotion compared with haloperidol treatment. Additionally, all patients who received risperidone demonstrated improvement in performance between baseline and retest, compared with four of the nine patients who received haloperidol. When changes in positive symptoms were statistically controlled, the results remained significant. These findings suggest that resperidone may facilitate patients' ability to accurately perceive emotion, an effect which may be mediated either directly by risperidone's pharmacological action or perhaps indirectly by its influence on basic neurocognition.


Subject(s)
Antipsychotic Agents/pharmacology , Emotions , Haloperidol/pharmacology , Risperidone/pharmacology , Schizophrenia/drug therapy , Schizophrenic Psychology , Adult , Analysis of Variance , Antipsychotic Agents/therapeutic use , Double-Blind Method , Drug Resistance , Female , Haloperidol/therapeutic use , Humans , Male , Risperidone/therapeutic use , Schizophrenia/physiopathology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...